Under the agreement, Bionova will serve as the preferred manufacturing partner for Syenex’s best-in-class delivery platforms.

A novel lentiviral packaging system enables production from a single-plasmid transfection instead of the standard four-plasmid process.

AGC Biologics signed a licensing agreement to use Asimov’s lentiviral packaging system, enabling production from a single-plasmid transfection.

A single damaged protein inside one brain cell may seem insignificant. Yet new research shows how that small mistake can ...

Gradalis announces positive results from phase 2b VITAL trial of Vigil to treat patients with newly diagnosed Stage IIIb–IV epithelial ovarian cancer: Dallas Friday, January 16, ...

Inovio Pharmaceuticals ( (INO)) has provided an announcement. On December 29, 2025, INOVIO announced that the U.S. Food and Drug Administration accepted for review its Biologics License Application ...

With the decision by the U.S. Food and Drug Administration and the European Commission to grant market authorization for Waskyratm, a gene therapy to treat Wiskott-Aldrich syndrome, AGC Biologics' ...

Opportunities in the mRNA quality monitoring market include the rising demand for QC due to the expansion of mRNA ...

This further establishes the global leadership of AGC Biologics' Milan Cell and Gene Center of Excellence in number of commercial products approvedMILAN--(BUSINESS WIRE)--#CGT--With the decision by ...

The study reveals that environmental stressors do not merely kill bacteria; they can also prime surviving cells to take up ...

Single-use systems streamline CGT manufacturing by reducing cleaning validation and enabling quick changeovers, essential for ...